Idience, a cancer drug development company of Ildong Pharmaceutical Group, announced on the 12th that it has signed a joint development agreement with Aptis, a subsidiary of Dong-A Socio Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback